PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

DEB-TACE

It is suggested that the tumor feeding artery should be selected for the microcatheter. The mixed volume of pirarubicin 80mg + microsphere 2g is about 2ml, and the mixture of at least 10ml and contrast medium is slowly injected with 5-10min.

PROCEDURE

PVL/PVE+DEB-TACE

DEB-TACE will be performed after the liver function recovered within 7-10 days. After that, conventional transarterial chemoembolization(cTACE) was performed every 2 months, a total of 2-3 times of chemoembolization.

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER